Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 04-2026 | 01-2026 | 10-2025 | 07-2025 | 04-2025 | |
| Sales | 506 | 444 | 708 | 764 | 491 |
| Cost of Goods | 237 | 206 | 258 | 296 | 208 |
| Gross Profit | 269 | 238 | 450 | 468 | 283 |
| Operating Expenses | 1,024 | 1,127 | 1,087 | 1,100 | 1,075 |
| Operating Income | -518 | -683 | -379 | -336 | -584 |
| Interest Expense | 106 | 101 | 94 | 89 | 78 |
| Other Income | 0 | -1 | 9 | 93 | 82 |
| Pre-tax Income | -624 | -785 | -464 | -332 | -580 |
| Net Income Continuous | -624 | -785 | -464 | -332 | -580 |
| Net Income | $-624 | $-785 | $-464 | $-332 | $-580 |
| EPS Basic Total Ops | -0.01 | -0.01 | 0.00 | 0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | 0.00 | 0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Before Non-Recurring Items | -0.01 | -0.01 | 0.00 | -0.01 | -0.01 |
| EBITDA(a) | $-518 | $-682 | $-378 | $-336 | $-583 |